Boryung Pharm - Asset Resilience Ratio

Latest as of September 2025: 8.59%

Boryung Pharm (003850) has an Asset Resilience Ratio of 8.59% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 003850 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩116.42 Billion
≈ $78.89 Million USD Cash + Short-term Investments

Total Assets

₩1.36 Trillion
≈ $918.96 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2009–2024)

This chart shows how Boryung Pharm's Asset Resilience Ratio has changed over time. See 003850 total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Boryung Pharm's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Boryung Pharm stock valuation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩116.42 Billion 8.59%
Total Liquid Assets ₩116.42 Billion 8.59%

Asset Resilience Insights

  • Limited Liquidity: Boryung Pharm maintains only 8.59% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Boryung Pharm Industry Peers by Asset Resilience Ratio

Compare Boryung Pharm's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 3.73%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 9.09%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.02%
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
Drug Manufacturers - Specialty & Generic 0.01%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%

Annual Asset Resilience Ratio for Boryung Pharm (2009–2024)

The table below shows the annual Asset Resilience Ratio data for Boryung Pharm.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.40% ₩4.67 Billion
≈ $3.17 Million
₩1.16 Trillion
≈ $788.89 Million
+0.01pp
2023-12-31 0.39% ₩3.59 Billion
≈ $2.44 Million
₩915.51 Billion
≈ $620.43 Million
+0.19pp
2022-12-31 0.21% ₩1.84 Billion
≈ $1.25 Million
₩892.39 Billion
≈ $604.76 Million
-5.92pp
2021-12-31 6.12% ₩50.73 Billion
≈ $34.38 Million
₩828.64 Billion
≈ $561.56 Million
-3.94pp
2020-12-31 10.06% ₩65.21 Billion
≈ $44.19 Million
₩647.99 Billion
≈ $439.14 Million
+10.02pp
2019-12-31 0.04% ₩213.73 Million
≈ $144.85K
₩507.63 Billion
≈ $344.01 Million
-0.01pp
2018-12-31 0.05% ₩213.18 Million
≈ $144.47K
₩450.02 Billion
≈ $304.97 Million
-0.01pp
2017-12-31 0.05% ₩214.70 Million
≈ $145.50K
₩402.52 Billion
≈ $272.78 Million
-0.05pp
2016-12-31 0.10% ₩410.37 Million
≈ $278.10K
₩397.90 Billion
≈ $269.65 Million
+0.10pp
2012-12-31 0.00% ₩3.82 Million
≈ $2.59K
₩273.01 Billion
≈ $185.01 Million
0.00pp
2011-12-31 0.00% ₩3.76 Million
≈ $2.55K
₩262.39 Billion
≈ $177.82 Million
+0.00pp
2010-12-31 0.00% ₩2.29 Million
≈ $1.55K
₩245.86 Billion
≈ $166.61 Million
0.00pp
2009-12-31 0.00% ₩2.29 Million
≈ $1.55K
₩176.79 Billion
≈ $119.80 Million
--
pp = percentage points

About Boryung Pharm

KO:003850 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$569.08 Million
₩839.74 Billion KRW
Market Cap Rank
#11865 Global
#371 in Korea
Share Price
₩9940.00
Change (1 day)
-1.39%
52-Week Range
₩8170.00 - ₩10680.00
All Time High
₩21257.60
About

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, So… Read more